The mark consists of a circular design depicted obliquely being intersected by a curved v-shape element pointing to a small dot on the other side of the circular design.
Mark For: This trademark registration is intended to cover the categories of
>Color is not claimed as a feature of the mark. The mark consists of a circular design depicted obliquely being intersected by a curved v-shape element pointing to a small dot on the other side of the circular design.
Research | OneLook Acronym Finder |
Serial Number | 88801666 |
Registration Number | 1551551 |
Mark Literal Elements | None |
Mark Drawing Type | 2 - AN ILLUSTRATION DRAWING WITHOUT ANY WORDS(S)/ LETTER(S)/NUMBER(S) |
Mark Type | TRADEMARK. SERVICE MARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2021-01-12 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | John C. Baum |
Attorney Docket Number | SEATTLE00027 |
2020-02-18 | Application Filed |
2020-02-21 | Location: NEW APPLICATION PROCESSING |
2020-02-21 | Status: Live/Pending |
2020-02-21 | Transaction Date |
2020-11-17 | Published |
2021-01-12 | Location: INTENT TO USE SECTION |
2021-06-30 | Status: A first request for extension of time to file a Statement of Use has been granted. |
Party: | SEAGEN INC. |
Address | 21823 30TH DRIVE S.E. BOTHELL, WASHINGTON UNITED STATES 98021 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Party: | Seattle Genetics, Inc. |
Address | 21823 30th Drive S.E. Bothell, WASHINGTON UNITED STATES 98021 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Application | APPLICATION/XML,IMAGE/JPEG | 2020-02-18 |
Drawing | IMAGE/JPEG | 2020-02-18 |
Design Search Code Corr Project | APPLICATION/XML | 2020-02-25 |
Notation to File | XML | 2020-05-12 |
Offc Action Outgoing | XML | 2020-05-12 |
XSearch Search Summary | XML | 2020-05-12 |
Change Address or Representation Form | XML | 2020-08-13 |
Response to Office Action | XML | 2020-09-14 |
Amendment and Mail Process Complete | MULTI | 2020-09-16 |
TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-10-10 |
Notice of Publication | XML | 2020-10-28 |
Notification Of Notice of Publication | XML | 2020-10-28 |
OG Publication Confirmation | APPLICATION/XML | 2020-11-17 |
Notice of Allowance | XML | 2021-01-12 |
Extension of Time to File SOU | APPLICATION/XML | 2021-06-30 |
ITU Extension Approval | APPLICATION/XML | 2021-07-02 |
ITU Unit Action | APPLICATION/XML,IMAGE/JPEG | 2021-07-02 |
26.01.03 | Circles, incomplete (more than semi |
26.01.13 | Circles, two (not concentric); Two circles |
26.01.21 | Circles that are totally or partially shaded. |
26.17.09 | Bands, curved; Bars, curved; Curved line(s), band(s) or bar(s); Lines, curved |
26.17.12 | Angles (geometric); Chevrons |
260102 | Circles, plain single line; Plain single line circles |
260103 | Circles, incomplete (more than semi |
260113 | Circles, two (not concentric); Two circles |
260121 | Circles that are totally or partially shaded. |
261709 | Bands, curved; Bars, curved; Curved line(s), band(s) or bar(s); Lines, curved |
261712 | Angles (geometric); Chevrons |
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals for the treatment of diseases and conditions, in particular, disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system and for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology
IC 042. US 100 101. G & S: Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
DM0000 | The mark consists of a circular design depicted obliquely being intersected by a curved v-shape element pointing to a small dot on the other side of the circular design. |
Description | Date |
---|---|
Trademark Assignment 7137-0369 [4 Pages] | 2020-12-16 |
Description | Date | Proceeding Number |
---|---|---|
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-07-02 | |
TEAS EXTENSION RECEIVED | 2021-06-30 | |
EXTENSION 1 GRANTED | 2021-06-30 | 98765 |
EXTENSION 1 FILED | 2021-06-30 | 98765 |
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2021-01-13 | |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-01-12 | |
PUBLISHED FOR OPPOSITION | 2020-11-17 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-11-17 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-10-28 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-10-09 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-09-15 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-09-14 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-09-14 | 88889 |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-08-13 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-08-13 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-08-13 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-05-12 | 6325 |
NON-FINAL ACTION WRITTEN | 2020-05-12 | 94482 |
NON-FINAL ACTION E-MAILED | 2020-05-12 | 6325 |
ASSIGNED TO EXAMINER | 2020-05-06 | 94482 |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2020-02-25 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-02-22 | |
NEW APPLICATION ENTERED IN TRAM | 2020-02-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.